tirzepatide drug shortage list Resolved: What It Means for Your Weight Loss Journey FDA reconsidering its decision to

Download your PDF copy by clicking here

Weight Loss Results: In a 48-week trial with people who had obesity: 12 mg dose: Average weight loss of 24.2% 8 mg dose: Average weight loss of 17.5% Placebo: Weight loss of 2.1% Let me put that in perspective: If you weigh 250 pounds: 24.2% weight loss = 60 pounds lost And people were still losing weight when the trial ended (no plateau reached yet) How this compares to other medications: Semaglutide (Wegovy): ~15% weight loss Tirzepatide (Zepbound): ~20% weight loss Retatrutide: ~24% weight loss This is the most significant weight loss we've seen with any medication to date

Mistake #1: Shaking the Vial

approval varies by country

The pharmacy prepares your medication, packages it, and ships it directly to your address

You should not use this medicine if you are breast-feeding, as it is unknown if it passes into breast milk